DIATRIZOATE MEGLUMINE

DIATRIZOATE MEGLUMINE was reported 373 times

DIATRIZOATE MEGLUMINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 2 0.0190
1 ONYCHOMADESIS 63 0.0150
2 RHEUMATIC FEVER 66 0.0148
3 ONYCHOMYCOSIS 64 0.0146
4 ACQUIRED PORPHYRIA 1 0.0141
5 C-REACTIVE PROTEIN ABNORMAL 61 0.0095
6 HEPATIC ENZYME 1 0.0067
7 FACET JOINT SYNDROME 21 0.0064
8 HYPOCHOLESTEROLAEMIA 2 0.0057
9 PEMPHIGUS 68 0.0054
10 EOSINOPHIL PERCENTAGE DECREASED 1 0.0050
11 PERIPHERAL VENOUS DISEASE 20 0.0049
12 RENAL CORTICAL NECROSIS 1 0.0043
13 PERICARDITIS 69 0.0041
14 BLEPHAROSPASM 23 0.0036
15 SYNOVITIS 64 0.0035
16 WOUND INFECTION PSEUDOMONAS 1 0.0032
17 CARBON DIOXIDE ABNORMAL 1 0.0032
18 HYPERAESTHESIA TEETH 4 0.0032
19 BACK INJURY 30 0.0028
20 MYOSCLEROSIS 1 0.0027
21 BREAST CANCER STAGE III 17 0.0026
22 ALKALOSIS 1 0.0026
23 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 4 0.0026
24 UPPER EXTREMITY MASS 1 0.0026
25 PRODUCT LABEL CONFUSION 15 0.0026
26 WOUND 71 0.0025
27 MUSCLE INJURY 21 0.0025
28 LYMPHOCYTE PERCENTAGE INCREASED 1 0.0025
29 DUODENAL ULCER PERFORATION 17 0.0023
30 FINGER DEFORMITY 11 0.0023
31 DEGENERATIVE BONE DISEASE 1 0.0023
32 BILIARY SEPSIS 1 0.0022
33 SKIN FIBROSIS 1 0.0021
34 TYPE 2 DIABETES MELLITUS 69 0.0020
35 CONTRAINDICATED PRODUCT ADMINISTERED 62 0.0020
36 SYSTEMIC LUPUS ERYTHEMATOSUS 68 0.0019
37 NEUTROPHIL PERCENTAGE DECREASED 1 0.0019
38 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 13 0.0018
39 PRESBYOPIA 1 0.0018
40 C-REACTIVE PROTEIN INCREASED 65 0.0018
41 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 1 0.0018
42 EUSTACHIAN TUBE DYSFUNCTION 1 0.0017
43 WOUND INFECTION 19 0.0017
44 BURSITIS 21 0.0017
45 PSORIATIC ARTHROPATHY 69 0.0017
46 X-RAY ABNORMAL 3 0.0017
47 URINARY TRACT INFECTION PSEUDOMONAL 1 0.0017
48 HYPERCHOLESTEROLAEMIA 16 0.0017
49 NORMAL NEWBORN 9 0.0017
50 CARDIAC PROCEDURE COMPLICATION 1 0.0016
51 THERAPEUTIC PRODUCT EFFECT DECREASED 70 0.0016
52 LIP DRY 13 0.0014
53 OVERLAP SYNDROME 1 0.0014
54 NAIL DISORDER 12 0.0014
55 INFUSION SITE REACTION 4 0.0013
56 OBESITY 20 0.0013
57 GRIP STRENGTH DECREASED 11 0.0012
58 FOLLICULITIS 13 0.0012
59 BOTULISM 1 0.0012
60 TASTE DISORDER 23 0.0011
61 LUNG TRANSPLANT 4 0.0011
62 JOINT RANGE OF MOTION DECREASED 15 0.0011
63 INCISION SITE INFECTION 1 0.0011
64 CERUMEN IMPACTION 1 0.0011
65 LIVE BIRTH 9 0.0011
66 HELICOBACTER INFECTION 11 0.0011
67 ILL-DEFINED DISORDER 64 0.0011
68 HIGH DENSITY LIPOPROTEIN INCREASED 1 0.0010
69 INFUSION RELATED REACTION 64 0.0010
70 INJECTION SITE REACTION 64 0.0009
71 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 6 0.0009
72 SLEEP DISORDER 65 0.0009
73 COELIAC DISEASE 9 0.0009
74 SOFT TISSUE DISORDER 1 0.0009
75 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 64 0.0009
76 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 2 0.0009
77 TREATMENT FAILURE 71 0.0009
78 LUPUS VULGARIS 1 0.0008
79 ASPERGILLOSIS 1 0.0008
80 HAND DEFORMITY 10 0.0008
81 HYPOVITAMINOSIS 1 0.0008
82 EPILEPSY 23 0.0008
83 ANION GAP INCREASED 1 0.0007
84 GAIT INABILITY 24 0.0007
85 PURULENT DISCHARGE 3 0.0007
86 PELVIC VENOUS THROMBOSIS 1 0.0007
87 LIVER INJURY 17 0.0007
88 RHEUMATOID FACTOR POSITIVE 4 0.0007
89 UNDERDOSE 50 0.0007
90 INTENTIONAL PRODUCT USE ISSUE 60 0.0007
91 SWELLING 62 0.0007
92 FIBROMYALGIA 16 0.0007
93 JOINT DESTRUCTION 1 0.0006
94 OPHTHALMOPLEGIA 1 0.0006
95 GLOSSODYNIA 14 0.0006
96 IRRITABLE BOWEL SYNDROME 13 0.0006
97 ADVERSE REACTION 8 0.0006
98 GAZE PALSY 1 0.0006
99 RETINITIS 1 0.0006
100 WOUND INFECTION STAPHYLOCOCCAL 1 0.0006
101 RHEUMATOID ARTHRITIS 65 0.0006
102 RIGHT VENTRICULAR FAILURE 4 0.0006
103 OSTEOARTHRITIS 24 0.0006
104 INCORRECT PRODUCT ADMINISTRATION DURATION 12 0.0006
105 LIVER FUNCTION TEST INCREASED 11 0.0005
106 NASAL SEPTUM DEVIATION 1 0.0005
107 DEEP VEIN THROMBOSIS POSTOPERATIVE 1 0.0005
108 PERIPHERAL ISCHAEMIA 2 0.0005
109 WHEEZING 29 0.0005
110 IMPAIRED HEALING 16 0.0005
111 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
112 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
113 SKIN INDURATION 1 0.0005
114 DRUG-INDUCED LIVER INJURY 15 0.0005
115 DEREALISATION 1 0.0005
116 URINE OUTPUT DECREASED 4 0.0005
117 CONFUSIONAL STATE 71 0.0004
118 DISLOCATION OF VERTEBRA 1 0.0004
119 NIGHT SWEATS 14 0.0004
120 EYELID DISORDER 1 0.0004
121 CONTRAST MEDIA REACTION 1 0.0004
122 THERAPY CHANGE 4 0.0004
123 BLOOD PRESSURE SYSTOLIC ABNORMAL 1 0.0004
124 CANCER PAIN 1 0.0004
125 HEPATITIS 10 0.0004
126 DISSEMINATED TUBERCULOSIS 1 0.0004
127 MEAN CELL VOLUME INCREASED 1 0.0004
128 BLOOD CHLORIDE DECREASED 1 0.0004
129 STOMATITIS 23 0.0004
130 LOWER RESPIRATORY TRACT INFECTION 17 0.0004
131 DRUG TOLERANCE DECREASED 1 0.0004
132 SKIN HYPERTROPHY 1 0.0004
133 CHOLECYSTITIS ACUTE 2 0.0004
134 PRODUCT USE ISSUE 66 0.0004
135 DERMATITIS CONTACT 4 0.0004
136 NEPHROGENIC SYSTEMIC FIBROSIS 1 0.0003
137 LUPUS-LIKE SYNDROME 3 0.0003
138 ECONOMIC PROBLEM 5 0.0003
139 EYE INJURY 1 0.0003
140 EXOSTOSIS 3 0.0003
141 LUNG DISORDER 16 0.0003
142 GENERALISED OEDEMA 4 0.0003
143 SCIATICA 5 0.0003
144 SWOLLEN JOINT COUNT INCREASED 1 0.0003
145 PORTAL VEIN THROMBOSIS 1 0.0003
146 HIATUS HERNIA 4 0.0003
147 DEAFNESS NEUROSENSORY 1 0.0003
148 PUSTULAR PSORIASIS 1 0.0003
149 HYPERTRANSAMINASAEMIA 2 0.0003
150 BONE EROSION 1 0.0003
151 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
152 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0003
153 PRODUCT USE IN UNAPPROVED INDICATION 67 0.0003
154 MATERNAL EXPOSURE TIMING UNSPECIFIED 1 0.0003
155 PROTEIN TOTAL DECREASED 1 0.0003
156 MOBILITY DECREASED 19 0.0003
157 OVERDOSE 57 0.0003
158 DRY MOUTH 21 0.0003
159 PATENT DUCTUS ARTERIOSUS 1 0.0003
160 MUSCLE FATIGUE 1 0.0002
161 METASTATIC NEOPLASM 1 0.0002
162 AMENORRHOEA 4 0.0002
163 ABDOMINAL ABSCESS 1 0.0002
164 PHYSICAL DISABILITY 1 0.0002
165 IRON DEFICIENCY 1 0.0002
166 SUSPECTED OFF LABEL USE 1 0.0002
167 INJURY 15 0.0002
168 MATERNAL EXPOSURE DURING PREGNANCY 19 0.0002
169 INFLAMMATION 11 0.0002
170 SKIN TIGHTNESS 1 0.0002
171 MIGRAINE 20 0.0002
172 DRUG INTOLERANCE 20 0.0002
173 RASH VESICULAR 1 0.0002
174 HEPATIC ENZYME INCREASED 14 0.0002
175 BONE LOSS 3 0.0002
176 GASTROOESOPHAGEAL REFLUX DISEASE 16 0.0002
177 OSTEOPENIA 3 0.0002
178 NECK PAIN 11 0.0002
179 AMMONIA INCREASED 1 0.0002
180 BLOOD CHOLESTEROL INCREASED 9 0.0002
181 BLOOD LACTIC ACID INCREASED 1 0.0002
182 MULTIPLE FRACTURES 3 0.0002
183 ARTHROPATHY 10 0.0002
184 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
185 PRODUCT QUALITY ISSUE 24 0.0002
186 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
187 ENTEROCOLITIS 1 0.0002
188 ASCITES 5 0.0002
189 OEDEMA 9 0.0002
190 RASH 72 0.0002
191 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
192 EXPOSURE DURING PREGNANCY 10 0.0002
193 BLISTER 9 0.0002
194 HEPATIC CIRRHOSIS 3 0.0002
195 HYPOPHAGIA 4 0.0002
196 PULMONARY FIBROSIS 3 0.0002
197 LOWER LIMB FRACTURE 3 0.0002
198 EAR PAIN 3 0.0002
199 MUSCULOSKELETAL PAIN 8 0.0002
200 JOINT STIFFNESS 4 0.0002
201 WRONG PRODUCT ADMINISTERED 1 0.0001
202 ULCER HAEMORRHAGE 1 0.0001
203 DISCOMFORT 9 0.0001
204 PRODUCT LABEL ISSUE 1 0.0001
205 DELIRIUM 5 0.0001
206 PAIN IN JAW 4 0.0001
207 MEMORY IMPAIRMENT 19 0.0001
208 PERIPHERAL SWELLING 21 0.0001
209 RESPIRATORY DISORDER 4 0.0001
210 GENERAL SYMPTOM 1 0.0001
211 DYSPEPSIA 13 0.0001
212 RENAL FAILURE CHRONIC 1 0.0001
213 PERICARDIAL EFFUSION 3 0.0001
214 WEIGHT INCREASED 29 0.0001
215 CONGENITAL ANOMALY 1 0.0001
216 CONCUSSION 1 0.0001
217 BLOOD ALBUMIN DECREASED 1 0.0001
218 DYSPNOEA 71 0.0001
219 ABDOMINAL DISTENSION 13 0.0001
220 FRUSTRATION TOLERANCE DECREASED 1 0.0001
221 STAPHYLOCOCCAL INFECTION 4 0.0001
222 PARAESTHESIA 19 0.0001
223 BREAST CANCER STAGE II 1 0.0001
224 HAEMODIALYSIS 1 0.0001
225 PAIN 73 0.0001
226 SINUSITIS 12 0.0001
227 SKIN HYPERPIGMENTATION 1 0.0001
228 URTICARIA 19 0.0001
229 GENERAL PHYSICAL HEALTH DETERIORATION 13 0.0001
230 MYOSITIS 1 0.0001
231 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
232 JOINT SWELLING 13 0.0001
233 NEPHROPATHY 1 0.0001
234 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
235 MUSCULOSKELETAL STIFFNESS 9 0.0001
236 AUTOIMMUNE DISORDER 1 0.0001
237 VITAMIN D DEFICIENCY 1 0.0001
238 RENAL TUBULAR NECROSIS 1 0.0001
239 PREGNANCY 2 0.0001
240 EYELID PTOSIS 1 0.0001
241 ADVERSE EVENT 9 0.0001
242 OSTEOPOROSIS 4 0.0001
243 OFF LABEL USE 85 0.0001
244 TEMPERATURE INTOLERANCE 1 0.0001
245 SKELETAL INJURY 1 0.0001
246 TOOTH LOSS 2 0.0001
247 BONE DENSITY DECREASED 3 0.0001
248 NAUSEA 75 0.0001
249 DECREASED APPETITE 22 0.0001
250 JOINT DISLOCATION 1 0.0001
251 DECREASED ACTIVITY 1 0.0001
252 OSTEONECROSIS 3 0.0001
253 GASTROINTESTINAL PAIN 1 0.0001
254 FOOT DEFORMITY 1 0.0001
255 HYPERTENSIVE CRISIS 1 0.0001
256 DEPRESSION 20 0.0001
257 ADRENAL INSUFFICIENCY 1 0.0001
258 PLEURAL EFFUSION 5 0.0001
259 SMALL INTESTINAL OBSTRUCTION 1 0.0001
260 HYPOAESTHESIA 12 0.0001
261 GASTROINTESTINAL DISORDER 7 0.0001
262 FALL 26 0.0001
263 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
264 EAR INFECTION 2 0.0001
265 MALIGNANT MELANOMA 1 0.0001
266 QUALITY OF LIFE DECREASED 1 0.0001
267 PERIPHERAL COLDNESS 1 0.0001
268 HYPOMAGNESAEMIA 1 0.0001
269 MUSCLE SPASMS 13 0.0001
270 PARALYSIS 1 0.0001
271 INFECTION 10 0.0001
272 DYSSTASIA 2 0.0001
273 LIVER DISORDER 3 0.0001
274 PULMONARY MASS 1 0.0001
275 IMMUNODEFICIENCY 1 0.0001
276 ALOPECIA 13 0.0001
277 HYPERTENSION 14 0.0001
278 DEVICE RELATED INFECTION 1 0.0001
279 HYPERSENSITIVITY 12 0.0001
280 ABDOMINAL PAIN UPPER 13 0.0001
281 PNEUMOTHORAX 1 0.0001
282 RESPIRATORY TRACT CONGESTION 1 0.0001
283 PREMATURE DELIVERY 1 0.0001
284 CONTUSION 6 0.0001
285 HIP FRACTURE 2 0.0001
286 MUSCULAR WEAKNESS 7 0.0001
287 BLOOD POTASSIUM INCREASED 1 0.0001
288 BACK DISORDER 1 0.0001
289 INSOMNIA 16 0.0001
290 SKIN DISORDER 2 0.0001
291 BLOOD UREA INCREASED 1 0.0001
292 NASOPHARYNGITIS 11 0.0001
293 ABDOMINAL DISCOMFORT 10 0.0001
294 DRUG INEFFECTIVE 78 0.0001
295 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
296 SCAR 1 0.0001
297 NEUROTOXICITY 1 0.0001
298 METASTASES TO LIVER 1 0.0001
299 HYPOXIA 2 0.0001
300 PANCREATITIS 3 0.0001
301 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
302 DRUG ERUPTION 1 0.0001
303 EYE SWELLING 2 0.0001
304 DYSARTHRIA 2 0.0001
305 HYPOCALCAEMIA 1 0.0001
306 FRACTURE 1 0.0001
307 FOOT FRACTURE 1 0.0001
308 PROTEINURIA 1 0.0001
309 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
310 HOSPITALISATION 8 0.0001
311 PRESCRIBED OVERDOSE 1 0.0001
312 KIDNEY INFECTION 1 0.0001
313 DISABILITY 1 0.0001
314 BLOOD PRESSURE ABNORMAL 1 0.0001
315 PRESCRIBED UNDERDOSE 1 0.0001
316 DIZZINESS 25 0.0001
317 EMOTIONAL DISTRESS 6 0.0000
318 CONDITION AGGRAVATED 15 0.0000
319 RIB FRACTURE 1 0.0000
320 RENAL IMPAIRMENT 4 0.0000
321 RENAL FAILURE ACUTE 2 0.0000
322 BLOOD CREATININE INCREASED 3 0.0000
323 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
324 ASTHENIA 17 0.0000
325 TRANSAMINASES INCREASED 1 0.0000
326 COLITIS ULCERATIVE 2 0.0000
327 RASH PAPULAR 1 0.0000
328 SNEEZING 1 0.0000
329 SKIN DISCOLOURATION 2 0.0000
330 ABDOMINAL PAIN 10 0.0000
331 RASH ERYTHEMATOUS 2 0.0000
332 PRESYNCOPE 1 0.0000
333 MALAISE 18 0.0000
334 PAIN IN EXTREMITY 12 0.0000
335 ENCEPHALOPATHY 1 0.0000
336 PNEUMONIA 13 0.0000
337 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
338 DIPLOPIA 1 0.0000
339 MUCOSAL INFLAMMATION 1 0.0000
340 ANHEDONIA 1 0.0000
341 BLOOD BILIRUBIN INCREASED 1 0.0000
342 FREQUENT BOWEL MOVEMENTS 1 0.0000
343 THROAT TIGHTNESS 1 0.0000
344 LIMB INJURY 1 0.0000
345 CARDIAC ARREST 3 0.0000
346 RESPIRATORY DISTRESS 1 0.0000
347 ARTHRALGIA 15 0.0000
348 HAEMOPTYSIS 1 0.0000
349 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
350 LABORATORY TEST ABNORMAL 1 0.0000
351 RENAL INJURY 1 0.0000
352 ADVERSE DRUG REACTION 3 0.0000
353 CORONARY ARTERY DISEASE 1 0.0000
354 DRUG ADMINISTRATION ERROR 1 0.0000
355 LIMB DISCOMFORT 1 0.0000
356 FEMUR FRACTURE 1 0.0000
357 SWOLLEN TONGUE 1 0.0000
358 DIARRHOEA 20 0.0000
359 MYALGIA 5 0.0000
360 PYREXIA 10 0.0000
361 BURNING SENSATION 2 0.0000
362 FATIGUE 22 0.0000
363 LYMPHADENOPATHY 1 0.0000
364 ANXIETY 8 0.0000
365 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
366 VOMITING 13 0.0000
367 NO ADVERSE EVENT 5 0.0000
368 CONSTIPATION 6 0.0000
369 DYSPNOEA EXERTIONAL 1 0.0000
370 CHRONIC KIDNEY DISEASE 2 0.0000
371 ANAEMIA 5 0.0000
372 ACUTE KIDNEY INJURY 4 0.0000
373 HEADACHE 16 0.0000
374 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
375 OEDEMA PERIPHERAL 3 0.0000
376 POLLAKIURIA 1 0.0000
377 ROAD TRAFFIC ACCIDENT 1 0.0000
378 RECTAL HAEMORRHAGE 1 0.0000
379 VAGINAL HAEMORRHAGE 1 0.0000
380 TACHYCARDIA 2 0.0000
381 THERAPY NON-RESPONDER 1 0.0000
382 TINNITUS 1 0.0000
383 COUGH 6 0.0000
384 COMA 1 0.0000
385 PRURITUS 8 0.0000
386 LEUKOPENIA 1 0.0000
387 HYPOTENSION 4 0.0000
388 FLUID RETENTION 1 0.0000
389 CHEST DISCOMFORT 2 0.0000
390 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
391 DEPRESSED MOOD 1 0.0000
392 ANAPHYLACTIC REACTION 1 0.0000
393 SEPSIS 2 0.0000
394 WEIGHT DECREASED 5 0.0000
395 FLATULENCE 1 0.0000
396 CONVULSION 1 0.0000
397 THERAPEUTIC RESPONSE DECREASED 1 0.0000
398 FEELING HOT 1 0.0000
399 VISUAL IMPAIRMENT 2 0.0000
400 GAIT DISTURBANCE 3 0.0000
401 LOSS OF CONSCIOUSNESS 2 0.0000
402 AMNESIA 1 0.0000
403 RENAL FAILURE 2 0.0000
404 RESPIRATORY FAILURE 1 0.0000
405 DYSGEUSIA 1 0.0000
406 DEATH 11 0.0000
407 ARTHRITIS 1 0.0000
408 DRUG ABUSE 1 0.0000
409 BALANCE DISORDER 1 0.0000
410 COVID-19 2 0.0000
411 SUICIDAL IDEATION 1 0.0000
412 BLOOD GLUCOSE INCREASED 2 0.0000
413 DYSPHAGIA 1 0.0000
414 ATRIAL FIBRILLATION 1 0.0000
415 HEART RATE INCREASED 1 0.0000
416 ERYTHEMA 2 0.0000
417 ILLNESS 1 0.0000
418 THROMBOCYTOPENIA 1 0.0000
419 ASTHMA 1 0.0000
420 PSORIASIS 1 0.0000
421 DEHYDRATION 1 0.0000
422 VISION BLURRED 1 0.0000
423 TOXICITY TO VARIOUS AGENTS 1 0.0000
424 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
425 CHEST PAIN 1 0.0000
426 SOMNOLENCE 1 0.0000
427 BACK PAIN 1 0.0000
428 FEELING ABNORMAL 1 0.0000